Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Jun;25(6):484–486. doi: 10.1136/jcp.25.6.484

Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity

C P Warlow 1, A McNeill 1, D Ogston 1, A S Douglas 1
PMCID: PMC477362  PMID: 5043373

Abstract

In a study of 41 fasting subjects it was confirmed that fibrinolytic activity was reduced in obese persons: an increase in fibrinogen was also associated with obesity. There was no correlation between obesity and the platelet count, platelet adhesiveness to glass, the level of serum fibrin degradation products, or the whole blood clotting time in plastic tubes.

Full text

PDF
484

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett N. B., Ogston C. M., McAndrew G. M., Ogston D. Studies on the fibrinolytic enzyme system in obesity. J Clin Pathol. 1966 May;19(3):241–243. doi: 10.1136/jcp.19.3.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett P. N. Postoperative changes in platelet adhesiveness. J Clin Pathol. 1967 Sep;20(5):708–709. doi: 10.1136/jcp.20.5.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bonnar J., Davidson J. F., Pidgeon C. F., McNicol G. P., Douglas A. S. Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J. 1969 Jul 19;3(5663):137–140. doi: 10.1136/bmj.3.5663.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DAWBER T. R., MOORE F. E., MANN G. V. Coronary heart disease in the Framingham study. Am J Public Health Nations Health. 1957 Apr;47(4 Pt 2):4–24. doi: 10.2105/ajph.47.4_pt_2.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GOLDRICK R. B. Fibrinolysis, blood clotting, serum lipids and body build in natives of New Guinea and Australians. Australas Ann Med. 1961 Feb;10:20–28. doi: 10.1111/imj.1961.10.1.20. [DOI] [PubMed] [Google Scholar]
  6. Grace C. S., Goldrick R. B. Fibrinolysis and body bulid. Interrelationships between blood fibrinolysis, body composition and parameters of lipid and carbohydrate metabolism. J Atheroscler Res. 1968 Jul-Aug;8(4):705–719. doi: 10.1016/s0368-1319(68)80028-6. [DOI] [PubMed] [Google Scholar]
  7. Grace C. S., Goldrick R. B. Tissue fibrinolytic activity in obesity. Aust J Exp Biol Med Sci. 1969 Jun;47(3):397–400. doi: 10.1038/icb.1969.44. [DOI] [PubMed] [Google Scholar]
  8. Grace C. S., Sinnett P. F., Whyte H. M. Blood fibrinolysis and coagulation in New Guineans and Australians. Australas Ann Med. 1970 Nov;19(4):328–333. doi: 10.1111/imj.1970.19.4.328. [DOI] [PubMed] [Google Scholar]
  9. Ham J. M., Slack W. W. Platelet adhesiveness after operation. Br J Surg. 1967 May;54(5):385–389. doi: 10.1002/bjs.1800540516. [DOI] [PubMed] [Google Scholar]
  10. KEMSLEY W. F., BILLEWICZ W. Z., THOMSON A. M. A new weight-for-height standard based on British anthropometric data. Br J Prev Soc Med. 1962 Oct;16:189–195. doi: 10.1136/jech.16.4.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kakkar V. V., Howe C. T., Nicolaides A. N., Renney J. T., Clarke M. B. Deep vein thrombosis of the leg. Is there a "high risk" group? Am J Surg. 1970 Oct;120(4):527–530. doi: 10.1016/s0002-9610(70)80023-x. [DOI] [PubMed] [Google Scholar]
  12. MCDONALD L., BRAY C., FIELD C., LOVE F., DAVIES B. HOMOCYSTINURIA, THROMBOSIS, AND THE BLOOD-PLATELETS. Lancet. 1964 Apr 4;1(7336):745–746. doi: 10.1016/s0140-6736(64)92852-1. [DOI] [PubMed] [Google Scholar]
  13. McDONALD L. Coagulability of the blood in ischaemic heart-disease. Lancet. 1957 Sep 7;273(6993):457–460. doi: 10.1016/s0140-6736(57)90768-7. [DOI] [PubMed] [Google Scholar]
  14. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  15. Negus D., Pinto D. J., Brown N. Platelet adhesiveness in postoperative deep-vein thrombosis. Lancet. 1969 Feb 1;1(7588):220–224. doi: 10.1016/s0140-6736(69)91239-2. [DOI] [PubMed] [Google Scholar]
  16. OGSTON D., MCANDREW G. M. FIBRINOLYSIS IN OBESITY. Lancet. 1964 Dec 5;2(7371):1205–1207. doi: 10.1016/s0140-6736(64)91042-6. [DOI] [PubMed] [Google Scholar]
  17. Ogston C. M., Ogston D. Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol. 1966 Jul;19(4):352–356. doi: 10.1136/jcp.19.4.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. PLOUG J., KJELDGAARD N. O. Urokinase an activator of plasminogen from human urine. I. Isolation and properties. Biochim Biophys Acta. 1957 May;24(2):278–282. doi: 10.1016/0006-3002(57)90194-4. [DOI] [PubMed] [Google Scholar]
  19. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  20. SHAW D. A., MACHAUGHTON D. Relationship between blood fibrinoytic activity and body fatness. Lancet. 1963 Feb 16;1(7277):352–354. doi: 10.1016/s0140-6736(63)91381-3. [DOI] [PubMed] [Google Scholar]
  21. SHERRY S., LINDEMEYER R. I., FLETCHER A. P., ALKJAERSIG N. Studies on enhanced fibrinolytic activity in man. J Clin Invest. 1959 May;38(5):810–822. doi: 10.1172/JCI103863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. STAMLER J., LINDBERG H. A., BERKSON D. M., SHAFFER A., MILLER W., POINDEXTER A. Prevalence and incidence of coronary heart disease in strata of the labor force of a Chicago industrial corporation. J Chronic Dis. 1960 Apr;11:405–420. doi: 10.1016/0021-9681(60)90046-1. [DOI] [PubMed] [Google Scholar]
  23. Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J. 1969 Jun 14;2(5658):651–657. doi: 10.1136/bmj.2.5658.651. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES